Item 8.01. Other Events.

On January 12, 2022, Oramed Pharmaceuticals Inc. (the "Company") issued a press release containing a letter to the Company's shareholders by its Chief Executive Officer, Nadav Kidron. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d)  Exhibits.



99.1   Press release dated January 12, 2022
104  Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       1

© Edgar Online, source Glimpses